RETRACTED ARTICLE: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2

Table 2 Correlation between LATS2 expression and clinicopathological features of gastric cancer

Groups	n	LATS2 expression		P
Groups	n	High	Low	P
Gender				0.165
Male	267	86	181
Female	90	22	68
Age (year)				0.797
≥ 60	202	60	142
< 60	155	48	107
Tumor size				0.572
≥ 5	252	74	178
< 5	105	34	71
Borrmann’s types				0.975
Bor.I + II	30	9	21
Bor.III + IV	327	99	228
WHO’s histological types				0.424
Papillary adenocarcinoma	6	3	3
Tubular adenocarcinoma
Well differentiated	10	5	5
Moderately differentiated	80	23	57
Poorly differentiated	219	68	151
Signet ring cell adenocarcinoma	27	6	21
Mucinous adenocarcinoma	15	3	12
Lauren’s types				0.211
Intestinal	96	25	71
Diffuse	180	60	120
Mixed	81	23	58
Depth of invasion				0.615
T1 + 2	26	9	17
T3 + 4	331	99	232
Lymph node metastasis				0.503
N0	78	26	52
N1–3	279	82	197
Distant metastasis				0.130
M0	345	102	243
M1	12	6	6
TNM staging				0.047
I + II	100	38	62
III + IV	257	70	187

ISSN: 1475-2867